At a glance
ClinicalIndex Comparison RecordN/ACompleted· 111 enrolled
Drug / intervention
SHADE Ultraviolet Sensor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
In Brief
A clinical study evaluating SHADE Ultraviolet Sensor and Standard of care counseling for Skin Cancer and 4 related conditions. Completed, enrolled 111 participants across 1 site.
Detailed Summary
This study will evaluate the safety and effectiveness of Shade for the management of UV-induced skin complications and data collected from this study will be used to support the proposed indications for use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Cancer, Actinic Keratoses, Ultraviolet-Induced Change in Normal Skin, Behavior, Health, Behavior, Risk Reduction
CountriesUnited States
CollaboratorsYouV Labs Inc.
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedOct 2017
Primary CompletionJan 2019
Study CompletionMar 2019
TodayJul 2026
First PostedOct 20, 2017
Enrollment StartOct 11, 2017
Primary CompletionJan 31, 2019
Study CompletionMar 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.7 years ago
Interventions
SHADE Ultraviolet Sensordevice
Patients will wear device for 6 months in addition to their own method of photo-protection.
Standard of care counselingbehavioral
Patients will use their own method of photo-protection